John Paulson Paulson & Co
John Paulson is the founder of Paulson & Co., a firm that became world-famous for profits related to the 2007–2008 housing and credit crisis. Beyond that landmark trade, the firm has pursued merger arbitrage, event-driven, and opportunistic credit and equity strategies. Paulson remains one of the most recognized names in modern hedge fund history.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$172M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
+$28.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$19.3M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$984K |
| 3 |
DSEY
Diversey Holdings, Ltd. Ordinary Shares
DSEY
|
+$420K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.75% |
| 2 | Materials | 31.68% |
| 3 | Financials | 15.53% |
| 4 | Technology | 3.36% |
| 5 | Real Estate | 0.74% |
Similar funds
John Paulson's Q3 2023 Portfolio in Review
As of Q3 2023, John Paulson held 21 positions worth $1.12B, up 9.1% from $1.02B the previous quarter. Its ten largest holdings account for 92% of the portfolio.
John Paulson deployed $180M of net new capital in Q3 2023, adding to 2 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 34% a quarter earlier, followed by Materials and Financials.
On the sell side, the most notable exit was Newmont, an estimated $19.3M sold.
- John Paulson added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2023, an estimated $172M increase.
- John Paulson fully exited Newmont in Q3 2023, selling an estimated $19.3M.
- John Paulson's ten largest holdings make up 92% of its $1.12B portfolio in Q3 2023.
- John Paulson opened 0 new positions and closed 3 in Q3 2023.
- John Paulson's portfolio value rose 9.1% quarter-over-quarter to $1.12B.
Based on Paulson & Co's 13F filing for Q3 2023, filed 14 Nov 2023.